Skip to main content
. Author manuscript; available in PMC: 2014 Sep 8.
Published in final edited form as: J Psychosom Res. 2011 Sep 22;71(6):423–428. doi: 10.1016/j.jpsychores.2011.08.003

Table 4.

Changes over time in fatigue

Time 1 Time 2 Time 3
Baseline: prior to chemotherapy (N = 26) Approximately 3 weeks following last chemotherapy1 (N = 23) Approximately 12 weeks following last treatment2 (N = 22)
Brief Fatigue Inventory (SD) P=0.252# 2.9 (1.8) 3.5a (2.4) 2.7b (2.5)
Additional Concerns subscale of FACIT3 (SD) P<0.001# 36.1 (11.1) 30.2c (13.5) 38.1d (12.7)
Single-item measure of fatigue severity (SD) P=0.026# 3.6 (2.8) 5.0e (3.4) 3.8 (3.4)

Notes:Higher scores on the Additional Concerns subscale of FACIT represent less fatigue and higher scores on the other two measures indicate greater fatigue.

1

One of the 23 patients had radiation therapy concurrent with chemotherapy, and one patient had a surgical procedure following the completion of chemotherapy and prior to the second PSG assessment.

2

Following last chemotherapy or last radiation treatment if radiation therapy followed the conclusion of chemotherapy.

3

Functional Assessment of Chronic Illness Therapy-Fatigue.

#

Significance of the time effect using repeated-measures.

a

Significantly different from Baseline at P=0.005.

b

Significantly different from Time 2, P=0.012.

c

Significantly different from Baseline at P<0.001.

d

Significantly different from Time 2, P<0.001.

e

Significantly different from Baseline, P=0.022.